Home » Topics » BioWorld Science

BioWorld Science
RSS

IND clearance for anti-CD20 armed allogeneic gamma delta T-cell therapy ACE-1831 for NHL

June 21, 2022

New mouse model displays stable hyperglycemia without age-related morbidity

June 21, 2022

Study identifies novel genes causing male infertility

June 21, 2022

Ovarian fibrosis-mediated ovulation failure is reversible: study

June 21, 2022

New cyclin-dependent kinase inhibitors divulged by Allorion Therapeutics

June 21, 2022

Peking University describes radiation-activated tetravalent platinum complex

June 21, 2022

Shanghai Jemincare Pharmaceuticals, Jiangxi Jemincare Group patent vasopressin receptor antagonists

June 21, 2022

New phosphodiesterase PDE4B1 inhibitors discovered at Reistone Biopharma

June 21, 2022

Hangzhou Polymed Biopharmaceuticals identifies new G12C mutant KRAS inhibitors

June 21, 2022

Variant in ABO blood group gene associated with long COVID

June 21, 2022

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...